It has also been noted that like gal-3, the levels of gal-4 increase in proportion with the progression of PD (Cengiz et al., 2019), making gal-4 a possible biomarker for PD diagnosis and stage progression. This evidence concerns the gene LGALS4 and Parkinson disease.